Global Compaction Machines Market Set to Reach $7.3 Billion by 2030: Key Growth Drivers and Trends
Compaction Machines Market
Dublin, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The "Compaction Machines - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Compaction Machines was estimated at US$5.5 Billion in 2024 and is projected to reach US$7.3 Billion by 2030, growing at a CAGR of 4.9% from 2024 to 2030.
Why Are Compaction Machines Gaining Greater Prominence in Global Infrastructure Development?The accelerating pace of infrastructure development across the globe is bringing compaction machines into sharper focus as essential equipment in construction, road-building, and land development projects. These machines, designed to reduce the volume of soil, asphalt, and waste materials by compressing them, play a vital role in enhancing the stability, strength, and durability of constructed surfaces. Whether it's the creation of new highways, airports, railways, or urban expansion projects, compaction machines are a key determinant of the foundational integrity of such works.
The demand is particularly surging in emerging economies undergoing rapid urbanization and industrialization, where governments are investing in large-scale transportation and civil engineering projects. Even in mature markets, aging infrastructure and sustainability goals are pushing municipalities and private contractors to adopt more advanced compaction solutions that offer superior efficiency and environmental compatibility.
The market is evolving from reliance on traditional static and vibratory rollers to more intelligent, operator-assist machines that offer real-time compaction data, better fuel efficiency, and higher safety standards. This transformation reflects the growing integration of technology into civil engineering practices and a rising emphasis on long-term performance and cost savings.What Are the Key Growth Drivers Fueling the Global Market for Compaction Machines?The growth in the compaction machines market is driven by several factors related to technological progression, evolving application needs, and structural shifts in construction practices worldwide. One of the primary drivers is the surge in government-funded infrastructure projects, particularly in Asia-Pacific, Africa, and Latin America, where urbanization and transportation development are in full swing. These projects require heavy and medium-duty compaction machines for roads, airports, railways, and utilities installation. At the same time, the growing focus on sustainable construction is spurring demand for electric and hybrid compaction models that offer lower emissions and quieter operation.
Technological innovation is another major growth enabler advancements in telematics, GPS tracking, intelligent compaction systems, and remote diagnostics are making machines more productive, cost-effective, and easier to manage across multiple sites. On the consumer behavior front, the shift toward equipment rentals and pay-per-use models is changing how contractors access and use machinery, increasing machine turnover and driving aftermarket services. The rise in modular and smart city construction is also boosting the requirement for compact, high-precision machines that can operate in confined urban spaces without compromising on performance.
Additionally, stricter regulatory requirements for soil compaction standards and workplace safety are pushing construction firms to invest in technologically advanced machines that can deliver both compliance and efficiency. These collective trends are underpinning a strong and resilient growth trajectory for the global compaction machines market.Key Insights:
Market Growth: Understand the significant growth trajectory of the Heavy Compaction Machines segment, which is expected to reach US$5.0 Billion by 2030 with a CAGR of a 5.7%. The Light Compaction Machines segment is also set to grow at 3.2% CAGR over the analysis period.
Regional Analysis: Gain insights into the U.S. market, valued at $1.5 Billion in 2024, and China, forecasted to grow at an impressive 9.0% CAGR to reach $1.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Report Features:
Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
Company Profiles: Coverage of players such as Ammann Group, Atlas Copco AB, BOMAG GmbH, Caterpillar Inc., and more.
Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis.
Key updates include:
Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players, and refined focus on leading global brands and core players.
Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
Key Attributes:
Report Attribute
Details
No. of Pages
268
Forecast Period
2024 - 2030
Estimated Market Value (USD) in 2024
$5.5 Billion
Forecasted Market Value (USD) by 2030
$7.3 Billion
Compound Annual Growth Rate
4.9%
Regions Covered
Global
Key Topics Covered:
MARKET OVERVIEW
World Market Trajectories
Tariff Impact on Global Supply Chain Patterns
Compaction Machines - Global Key Competitors Percentage Market Share in 2025
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025
MARKET TRENDS & DRIVERS
Boom in Infrastructure Development Projects Throws the Spotlight on High-Performance Compaction Equipment
Growth in Road Construction Activities Drives Demand for Heavy-Duty and High-Frequency Rollers
Urbanization and Smart City Projects Expand the Addressable Market for Compact and Maneuverable Compaction Machines
Rising Adoption of Sustainable Construction Practices Strengthens the Business Case for Electric and Hybrid Compactors
Automation in Construction Equipment Propels Growth in Remote-Controlled and Semi-Autonomous Compaction Solutions
Push for Precision and Efficiency on Job Sites Spurs Adoption of Telematics-Enabled Compaction Monitoring
Shortage of Skilled Labor in Construction Drives Interest in Operator-Assistance Technologies and Ergonomic Designs
Growing Use of Recycled Materials in Road Bases Throws the Spotlight on Versatile and Adaptive Compaction Solutions
Rising Investments in Rural Connectivity and Agricultural Roads Generate Demand for Lightweight Compaction Equipment
Shift Toward Equipment Rental Models Expands Opportunities for OEMs with Scalable Product Lines
Integration of GPS and Intelligent Compaction Systems Drives Efficiency in Large-Scale Earthworks
Resilience Planning in Disaster-Prone Regions Propels Growth of High-Reliability, All-Terrain Compaction Machines
FOCUS ON SELECT PLAYERS
Some of the 34 companies featured in this Compaction Machines market report include:
Ammann Group
Atlas Copco AB
BOMAG GmbH
Caterpillar Inc.
Dynapac Compaction Equipment AB
Fayat Group
HAMM AG
Hitachi Construction Machinery Co., Ltd.
JCB Ltd.
John Deere
MBW Inc.
SANY Heavy Industry Co., Ltd.
SAKAI Heavy Industries, Ltd.
Terex Corporation
Tana Oy
Volvo Construction Equipment
Wacker Neuson SE
Wirtgen Group
XCMG Group
Zoomlion Heavy Industry Science & Technology Co., Ltd.
For more information about this report visit https://www.researchandmarkets.com/r/gcdnsz
About ResearchAndMarkets.comResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Attachment
Compaction Machines Market
CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood,Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Forbes
14 minutes ago
- Forbes
5 ChatGPT Prompts To Help Drive More Traffic To Your Website
By Richard D. Harroch and Dominique A. Harroch Getting more traffic to your website is one of the most important objectives for any business, startup, or entrepreneur. Website traffic means more visibility, more potential customers, and more opportunities to convert visits into revenue. But with so many competitors and constant changes in search engine optimization (SEO), content trends, and digital marketing tactics, attracting consistent traffic can feel overwhelming. This is where ChatGPT can be helpful. Whether you're a solo entrepreneur or a marketing team leader, OpenAI's powerful AI assistant can help you brainstorm, plan, write, and optimize your website content and strategy in ways that drive traffic. With the right prompts, ChatGPT can become a virtual assistant that can research your market, suggest improvements, and generate drafts of the kind of content your audience (and Google) loves. In this article, we'll share five high-impact ChatGPT prompts—along with sample variations—to help you grow your site's traffic. These prompts are practical, easy to implement, and designed to give you ideas and tools you can use right away. Naturally, we used ChatGPT for insights and research assistance for this article. 1. Identify High-Impact Keywords and SEO Topics SEO remains one of the most effective ways to attract organic traffic. But it starts with targeting the right keywords—phrases your potential visitors are searching for. ChatGPT can help you discover keyword ideas, group them into topics, and even suggest related questions that people ask. Example Prompt: 'I run a website that sells natural skincare products. Suggest 15 high-volume, low-competition SEO keywords I could target, and organize them into five blog post topic clusters.' Additional Sample Prompts: 2. Write Blog Posts That Rank and Convert Once you've identified strong SEO topics, ChatGPT can help you outline and write blog content that's both optimized for search engines and valuable to readers. From headlines and intros to structure and calls to action, you can co-create content that performs well and supports your broader marketing goals. Example Prompt: 'Write an outline and 500-word introduction for a blog post titled '10 Reasons to Switch to Natural Skincare Products.' Make it engaging, informative, and optimized for SEO.' Additional Sample Prompts: 3. Improve On-Page SEO and User Engagement Optimizing on-page elements like meta descriptions, headings, image alt text, and internal links can make a major difference in how search engines rank your content—and how users engage with it. ChatGPT can help fine-tune these details so your pages are more visible and inviting. Example Prompt: 'Here's the first paragraph of a blog post about productivity apps. Can you improve it for readability and SEO, and suggest a meta description, slug, and alt text for the main image?' Additional Sample Prompts: 4. Repurpose Content Across Channels Publishing a blog post is just the beginning. Smart marketers extend the value of their content by repurposing it into other formats—social media posts, email newsletters, video scripts, and more. ChatGPT can help you do this efficiently while maintaining a consistent message and brand voice. Example Prompt: 'I wrote a blog post titled 'How to Start a Consulting Business' found at [ Can you turn this into a five-part email series and three LinkedIn posts?' Additional Sample Prompts: 5. Analyze and Improve Underperforming Pages Sometimes your existing content isn't driving traffic—but that doesn't mean it's a lost cause. ChatGPT can help you review underperforming pages and suggest ways to refresh, optimize, or reposition them for better performance. This includes updating content, fixing SEO issues, or refining the angle to match current trends. Example Prompt: 'I have a blog post titled 'Best Productivity Tools for 2021' that used to get traffic but doesn't anymore. Can you help me rewrite and re-optimize it for current trends?' Additional Sample Prompts: Conclusion on Driving More Traffic to Your Website Driving more traffic to your website doesn't require hiring an expensive consultant or reinventing the wheel. With tools like ChatGPT, you can level up your content strategy, sharpen your SEO focus, and consistently publish content that attracts and engages your audience. The key is asking the right questions—and using AI as a thought partner and assistant to execute faster. Whether you're working solo or managing a team, the prompts above give you a starting point. From keyword research to content optimization and repurposing, ChatGPT can help you unlock growth opportunities and build long-term momentum for your website. Try these prompts, tweak them to your niche, and start seeing results. More from AllBusiness: Copyright (c) by Richard D. Harroch. All rights reserved.
Business Upturn
an hour ago
- Business Upturn
GENIUS Act: The Catalyst for Trillions in Real-World Asset Tokenization with Deal Box and OroBit
San Diego, CA , Aug. 04, 2025 (GLOBE NEWSWIRE) — The passage of the landmark GENIUS Act marks a defining moment for the digital asset industry, further opening the door for mainstream adoption of real-world asset (RWA) tokenization, an industry expected to surpass $16 trillion this decade. Positioned at the heart of this financial evolution are fintech pioneer Thomas Carter's Deal Box and blockchain infrastructure innovator OroBit—two firms uniquely prepared to harness these converging opportunities. The GENIUS Act provides explicit regulatory guidelines for stablecoins and digital assets, clarifying critical elements such as reserve requirements (mandating 100% reserves in USD or short-term Treasuries), monthly audits, AML compliance, and dual federal and state licensing oversight. These clear guidelines remove major uncertainties that have long constrained institutional participation, signaling an era of greater investor confidence and market stability. This regulatory clarity arrives during an unprecedented uptick in institutional interest in cryptocurrency markets, notably driven by recent Bitcoin ETF approvals and increasing investment from banks and asset managers. The crypto market capitalization has surged past $4 trillion, reflecting robust, ongoing confidence from institutional treasuries. Thomas Carter, CEO and founder of Deal Box, emphasized the strategic importance of this regulatory development: 'The GENIUS Act couldn't be better timed. The clarity and legitimacy it provides aligns perfectly with growing institutional confidence in digital assets. This convergence creates precisely the environment we've anticipated, enabling Deal Box and our partners at OroBit to rapidly scale tokenization solutions, especially in private equity and traditionally illiquid markets.' Since its inception in 2016, Deal Box has actively championed the tokenization of private equity and alternative assets, offering investors unprecedented access, transparency, and liquidity. Deal Box is also at the forefront of AI technology, partnering with Wild Mouse, an Australian enterprise software company, which has developed a globally unique platform designed to ingest, analyze, and act on unstructured data at scale, offering transformative potential for companies like OroBit. OroBit complements this vision with their sophisticated Smart Contract Layer (SCL), a robust blockchain protocol built on Bitcoin, securely automating tokenization, ownership management, and compliance processes, providing infrastructure for mainstream adoption. By leveraging Bitcoin—the largest and most secure blockchain—OroBit is strategically positioned to capture substantial value as the Bitcoin network itself experiences historic growth and adoption. Warwick Powell, Chairman of OroBit, highlighted the transformative impact of this legislation and strategic alignment: 'The GENIUS Act directly validates the infrastructure we've developed, clearing the path for institutional-grade adoption at a scale previously unimaginable. Alongside Deal Box, we're positioned to become the new standard-bearer for secure, compliant, and efficient tokenized financial products.' The unified ecosystem they have crafted, powered by an enterprise-grade AI platform, is redefining how private equity, real estate, art, and other high-value assets are owned, traded, and managed globally. The long-anticipated tokenization revolution is now underway. About Deal Box Deal Box is venture capital that fits your life. We bring institutional clarity to tokenized and traditional assets through credible AI structuring, Bitcoin-first token design, and packaging built for investor diligence. Structured for issuer-led offerings under Rule 506(c), Deal Box does not act as a broker-dealer or placement agent and receives no compensation tied to capital raised. contact: [email protected] About OroBit OroBit delivers secure, scalable Bitcoin Layer-2 solutions, enabling sophisticated smart-contract capabilities specifically tailored to institutional and private market asset tokenization. See for more information contact [email protected] Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
Business Upturn
an hour ago
- Business Upturn
CYCLACEL PHARMACEUTICALS HIGHLIGHTS PRECLINICAL DATA SHOWING THAT CANCER OF THE BILIARY TRACT IS SENSITIVE TO PLOGOSERTIB
– Biliary tract cancer (BTC) or cholangiocarcinoma is an aggressive tumor with poor prognosis – KUALA LUMPUR, Malaysia, Aug. 04, 2025 (GLOBE NEWSWIRE) — Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; 'Cyclacel' or the 'Company'), a biopharmaceutical company developing innovative cancer medicines, highlighted a preclinical study from independent investigators titled, ' Evaluation of antitumor effects of plogosertib, PLK1 inhibitor in biliary tract cancer with BUBR1 as a potential biomarker ' in the journal, Cancer Research, previously reported in a poster at the American Association of Cancer Research 2025 annual meeting.1 The investigators found that several BTC cancer cell lines were sensitive to plogosertib both as monotherapy and in combinations. Consistently with its antimitotic mechanism of action, plogosertib promoted mitotic checkpoint complex (MCC) formation in prometaphase, which induced mitotic arrest resulting in apoptosis of BTC cells. The authors have also found that BUBR1, a critical mitotic checkpoint protein, may be useful as a biomarker to assess plogosertib's effectiveness. BTC cells with high BUBR1 expression were found to be more sensitive to plogosertib compared to those with low expression. The study concluded that BTC cells with high BUBR1 expression are sensitive to the PLK1 inhibitor plogosertib that demonstrate synergistic effects when combined with an ATR inhibitor, which suggest that targeting PLK1 could be an effective strategy for BTC treatment, especially with BUBR1 expression as a potential biomarker to inform optimal combination therapies. About Biliary Tract Cancer (BTC) BTC, also called cholangiocarcinoma, is a rare but aggressive cancer occurring in the biliary tract, a network of small tubes, or ducts, connecting the liver, gallbladder and small intestine. According to estimates from the National Cancer Institute's SEER database annual US incidence of BTC is 4.4 per 100,000. Prognosis for BTC patients is poor with 5-year overall survival of approximately 10–40% even after surgical tumor resection. BTC treatment strategies include chemotherapy, surgery, radiation and targeted medicines depending on location and stage. As these approaches are not curative, there is an urgent, unmet medical need to treat patients with relapsed, refractory and/or unresectable BTC. About Polo-like Kinase and Plogosertib Polo-like kinase 1 (PLK1) is a serine/threonine kinase that plays a central role in cell division or mitosis. PLK1 is an important regulator of the DNA damage cell cycle checkpoint, mitotic entry and exit, spindle formation and cytokinesis, or cell separation into daughter cells. In general, cancer cells, and in particular KRAS mutated and p53(-) cells, are very sensitive to PLK1 depletion. In contrast normal cells with intact cell cycle checkpoints are less sensitive. Pharmacological inhibition of PLK1 in cancer cells blocks proliferation by prolonged mitotic arrest and induces onset of apoptotic death of such cells. Plogosertib (formerly CYC140) is a novel, small molecule, selective and potent PLK1 inhibitor. It has demonstrated impressive efficacy in human tumor xenografts at nontoxic doses. Cyclacel's translational biology program supports the development of plogosertib in solid tumors and leukemias. Preclinical data from independent groups have shown that certain ARID1A- and/or SMARCA-mutated cancers, and cancers associated with DNAJ-PKAc fusions, may benefit from treatment with plogosertib. Additionally, recent data suggest that PLK1 inhibition may be effective in KRAS-mutated metastatic colorectal cancer. PLK1 overexpression correlates with poor patient prognosis in several tumors, including biliary tract, esophageal, fibrolamellar liver, gastric, leukemia, lung, ovarian, and squamous cell cancers, as well as MYC-amplified cancers. Initial dose escalation data from a Phase 1 clinical study of oral plogosertib suggest that the compound is well tolerated with no dose limiting toxicity observed in five dosing schedules. Clinical benefit was observed in patients with adenoid cystic, biliary tract, ovarian, and squamous cell sinus cancers. About Cyclacel Pharmaceuticals, Inc. Cyclacel is a clinical-stage, biopharmaceutical company developing innovative cancer medicines based on cell cycle and mitosis biology. The anti-mitotic program is evaluating plogosertib, a PLK1 inhibitor, in patients with both solid tumors and hematological malignancies. Cyclacel's strategy is to build a diversified biopharmaceutical business based on a pipeline of novel drug candidates addressing oncology and hematology indications. For additional information, please visit Forward-looking Statements This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended and the Safe Harbor provisions of the US Private Securities Litigation Reform Act of 1995, and encompasses all statements, other than statements of historical fact contained in this press release. These forward-looking statements can be identified by terminology such as 'may,' 'could,' 'will,' 'expects,' 'anticipates,' 'aims,' 'future,' 'intends,' 'plans,' 'believes,' 'estimates,' 'targets,' 'likely to', 'understands' and similar statements. These forward-looking statements are based on management's current expectations. However, it is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. These statements are neither promises nor guarantees but involve known and unknown risks, uncertainties and other important factors and circumstances that may cause Cyclacel's actual results, performance or achievements to be materially different from its expectations expressed or implied by the forward-looking statements, including conditions in the U.S. capital markets, negative global economic conditions, potential negative developments resulting from epidemics or natural disasters, other negative developments in Cyclacel's business or unfavorable legislative or regulatory developments. We caution you therefore against relying on these forward-looking statements, and we qualify all of our forward-looking statements by these cautionary statements. For a discussion of additional factors that may affect the outcome of such forward-looking statements, see our 2024 annual report on Form 10-K, and in particular the 'Risk Factors' section, as well as the other documents filed with or furnished to the SEC by Cyclacel from time to time. Copies of these filings are available online from the SEC at or on the SEC Filings section of our Investor Relations website at These and other important factors could cause actual results to differ materially from those indicated by the forward-looking statements made in this press release. Any such forward-looking statements represent management's estimates as of the date of this press release. These forward-looking statements should not be relied upon as representing Cyclacel's views as of any date subsequent to the date of this press release. All forward-looking statements in this press release are based on information currently available to Cyclacel, and Cyclacel and its authorized representatives assume no obligation to update these forward-looking statements in light of new information or future events. Accordingly, undue reliance should not be placed upon the forward-looking statements. Contact Cyclacel Pharmaceuticals, Inc. Email: [email protected] © Copyright 2025 Cyclacel Pharmaceuticals, Inc. All Rights Reserved. The Cyclacel logo and Cyclacel® are trademarks of Cyclacel Pharmaceuticals, Inc. SOURCE: Cyclacel Pharmaceuticals, Inc. 1 Yoojin Jeong, Yoojin Jeong, et al, Abstract 5406: Evaluation of antitumor effects of plogosertib, PLK1 inhibitor in biliary tract cancer with BUBR1 as a potential biomarker, Cancer Res (2025) 85 (8 Supplement 1): 5406. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash
